Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion type Assertion NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_head.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion wasGeneratedBy ECO_0000203 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion wasDerivedFrom befree-20140225 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion SIO_000772 22935999 NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion evidence source_evidence_literature NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.
- NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_assertion description "[We used multiple analytical technologies, including immunoassays and immunoprecipitation followed by mass spectrometry (IP-MS) to characterize Aβ peptides and soluble APP fragments (sAPP-α/β) in cell media from pharmacologically (U18666A) and genetically (NPC1 ( -/- ) ) induced NPC cell models, and cerebrospinal fluid (CSF) from NPC cats and human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531839.RAfgYmYoDowU6u5gTw9ku85a8a1U4M7MAFL7orUpqCuzA130_provenance.